Poddubnaya, I. V., Al-Radi, L. S., Byalik, T. E., Kaplanov, K. D., Molostvova, V. Z., Nikitin, E. A., . . . Tumyan, G. S. (2020). ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution. IP Habib O.N.
Cita Chicago Style (17a ed.)Poddubnaya, Irina V., et al. ELEVATE-TN Study. New Data of Acalabrutinib in First-line Treatment of Chronic Lymphocytic Leukemia. Resolution. IP Habib O.N, 2020.
Cita MLA (8a ed.)Poddubnaya, Irina V., et al. ELEVATE-TN Study. New Data of Acalabrutinib in First-line Treatment of Chronic Lymphocytic Leukemia. Resolution. IP Habib O.N, 2020.
Precaución: Estas citas no son 100% exactas.